1. Home
  2. FSBW vs TSHA Comparison

FSBW vs TSHA Comparison

Compare FSBW & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBW
  • TSHA
  • Stock Information
  • Founded
  • FSBW 1936
  • TSHA 2019
  • Country
  • FSBW United States
  • TSHA United States
  • Employees
  • FSBW N/A
  • TSHA N/A
  • Industry
  • FSBW Banks
  • TSHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSBW Finance
  • TSHA Health Care
  • Exchange
  • FSBW Nasdaq
  • TSHA Nasdaq
  • Market Cap
  • FSBW 318.4M
  • TSHA 356.7M
  • IPO Year
  • FSBW 2012
  • TSHA 2020
  • Fundamental
  • Price
  • FSBW $37.49
  • TSHA $1.77
  • Analyst Decision
  • FSBW Hold
  • TSHA Strong Buy
  • Analyst Count
  • FSBW 1
  • TSHA 8
  • Target Price
  • FSBW $44.00
  • TSHA $6.63
  • AVG Volume (30 Days)
  • FSBW 11.2K
  • TSHA 1.5M
  • Earning Date
  • FSBW 04-23-2025
  • TSHA 05-13-2025
  • Dividend Yield
  • FSBW 2.90%
  • TSHA N/A
  • EPS Growth
  • FSBW N/A
  • TSHA N/A
  • EPS
  • FSBW 4.36
  • TSHA N/A
  • Revenue
  • FSBW $139,150,000.00
  • TSHA $8,333,000.00
  • Revenue This Year
  • FSBW $9.22
  • TSHA N/A
  • Revenue Next Year
  • FSBW $6.31
  • TSHA N/A
  • P/E Ratio
  • FSBW $8.55
  • TSHA N/A
  • Revenue Growth
  • FSBW 0.09
  • TSHA N/A
  • 52 Week Low
  • FSBW $30.64
  • TSHA $1.19
  • 52 Week High
  • FSBW $49.15
  • TSHA $4.32
  • Technical
  • Relative Strength Index (RSI)
  • FSBW 47.22
  • TSHA 59.56
  • Support Level
  • FSBW $36.05
  • TSHA $1.71
  • Resistance Level
  • FSBW $38.01
  • TSHA $1.82
  • Average True Range (ATR)
  • FSBW 0.95
  • TSHA 0.09
  • MACD
  • FSBW 0.06
  • TSHA 0.02
  • Stochastic Oscillator
  • FSBW 55.95
  • TSHA 82.76

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: